Frequently Asked Questions
What are the regulatory requirements for submitting a new dietary ingredient notification to the FDA?
The regulatory requirements for an FDA new dietary ingredient notification include submission at least 75 days before marketing, ingredient identity, manufacturing details, specifications, proposed use, labeling, and evidence demonstrating a reasonable expectation of safety.
How does REJIMUS assist companies in preparing their submission dossiers for dietary supplements?
REJIMUS assists companies with dietary supplement submission dossiers by evaluating regulatory requirements, reviewing scientific literature and consumption data, assessing safety, and preparing electronic New Dietary Ingredient Notification or GRAS documentation for FDA submission.
What is the process for conducting a safety evaluation for a new dietary ingredient?
The safety evaluation process for a new dietary ingredient includes reviewing scientific literature, toxicology, manufacturing data, historical use, and estimated consumption to assess safety and support an FDA New Dietary Ingredient Notification.
How can a company determine if their food ingredient qualifies for GRAS status?
Determining GRAS status involves reviewing scientific evidence, safety data, and qualified expert consensus to establish reasonable certainty of safety under intended use. Companies may document a GRAS self-determination or submit a notification to the FDA.
What services are offered to ensure compliance with the Federal Food, Drug, and Cosmetic Act?
The services supporting Federal Food, Drug, and Cosmetic Act compliance include NDI and GRAS notifications, feasibility assessments, literature reviews, historical-use analyses, safety evaluations, consumption data reviews, and expert panel or FDA submission support.
Can you explain the difference between a GRAS self-determination and an FDA notification?
The difference between a GRAS self-determination and an FDA notification is that self-determination relies on a company’s documented expert conclusion without FDA submission, while notification voluntarily submits the GRAS conclusion to FDA for review and response.
What documentation is required for electronic filing of dietary ingredient notifications?
The documentation required for electronic dietary ingredient notification filing includes the ingredient identity, manufacturing process, specifications, safety evidence, history of use, consumption data, and supporting scientific literature.
What steps are involved in filing a submission?
The steps involved in filing a submission are assessing eligibility, reviewing safety and consumption data, preparing the NDIN or GRAS dossier, submitting it electronically to the FDA, and addressing any follow-up questions.
How does REJIMUS support the electronic filing process?
REJIMUS supports the electronic filing process by preparing, reviewing, and submitting New Dietary Ingredient Notification (NDIN) dossiers to the FDA, ensuring required information is complete, accurate, and aligned with regulatory requirements.
What evidence is needed for a safety evaluation?
The evidence needed for a safety evaluation includes ingredient identity and composition, manufacturing information, intended use and exposure, toxicological data, relevant scientific literature, history of consumption, and consumption estimates.
Are expert panel reviews required for GRAS status?
Expert panel reviews are not legally required for GRAS status, but they can provide valuable independent scientific support, particularly for GRAS self-determinations and complex safety assessments.
How long does the agency review process take?
The agency review process typically takes several months, depending on submission complexity, completeness, and FDA questions. REJIMUS helps prepare a thorough dossier and manage responses to support an efficient review.
What are the common challenges with ingredient notifications?
Common challenges with ingredient notifications include compiling complete safety evidence, demonstrating regulatory compliance, evaluating consumption data, addressing FDA information requirements, and preparing accurate, well-supported NDIN or GRAS documentation.
How is historical use data utilized for compliance?
Historical use data is utilized for compliance by documenting an ingredient’s prior consumption, supporting safety evaluations, and informing FDA NDI or GRAS submissions when relevant evidence is reliable and adequately characterized.
What regulatory support does REJIMUS provide for supplements?
The regulatory support REJIMUS provides for supplements includes NDI notification preparation, FDA electronic filing, literature reviews, historical-use assessments, safety evaluations, consumption data analysis, and GRAS self-determination or expert panel support.
Why is a feasibility assessment necessary for companies?
The necessity of a feasibility assessment for companies lies in identifying regulatory requirements, potential safety concerns, supporting evidence, and submission risks early, helping determine whether an NDI Notification or GRAS pathway is practical before investing in product development.
How are dietary ingredients evaluated for safety standards?
Dietary ingredients are evaluated for safety standards through scientific literature reviews, toxicology data, historical consumption, intended-use assessments, and exposure estimates. FDA New Dietary Ingredient Notifications or GRAS evaluations document whether the ingredient is reasonably expected to be safe under proposed conditions of use.
What role does literature review play in submissions?
The role of literature review in submissions is to identify relevant scientific evidence, assess an ingredient’s safety and history of use, and support the scientific rationale for FDA NDI Notifications or GRAS conclusions.
How does REJIMUS help with federal compliance standards?
REJIMUS helps with federal compliance standards by providing FDA regulatory guidance, feasibility assessments, literature reviews, safety evaluations, and dossier preparation for New Dietary Ingredient Notifications and GRAS submissions.
What defines a successful dietary ingredient submission package?
A successful dietary ingredient submission package is defined by complete, accurate documentation, scientific evidence supporting safety, regulatory compliance, consumption data, literature reviews, and clear organization that enables efficient FDA evaluation.
Are there specific requirements for food additive safety?
Specific requirements for food additive safety include demonstrating a reasonable certainty of no harm, establishing appropriate use levels, evaluating toxicity and exposure data, and complying with FDA regulations. REJIMUS can support safety assessments and GRAS or food additive submissions.
How can companies prove their ingredients are safe?
Companies can prove ingredient safety by conducting scientific literature reviews, evaluating toxicology and consumption data, documenting historical use, and preparing FDA-compliant NDI Notifications or GRAS determinations supported by qualified experts.
What constitutes a comprehensive dossier for the FDA?
A comprehensive FDA dossier includes product identity, manufacturing details, specifications, intended use, consumption estimates, literature reviews, historical-use data, and thorough safety evidence supporting an NDI notification or GRAS conclusion.
How are consumption data evaluations conducted for products?
Consumption data evaluations are conducted by reviewing intake levels, serving sizes, use patterns, target populations, and available market data to estimate exposure and assess whether the product’s proposed use supports FDA safety requirements.
What expertise does REJIMUS offer for regulatory filings?
REJIMUS’s regulatory filing expertise includes NDI and GRAS notifications, FDA submission preparation, literature reviews, historical-use assessments, safety evaluations, consumption data analysis, and expert panel coordination.
How is the notification process managed for businesses?
The notification process for businesses is managed through regulatory review, document preparation, and electronic submission to the FDA. REJIMUS supports feasibility assessments, safety evaluations, dossier development, and submission follow-up for NDI and GRAS notifications.
What documents support a GRAS self-determination claim?
Documents supporting a GRAS self-determination claim include a detailed safety assessment, scientific literature review, historical-use evidence, identity and manufacturing data, exposure estimates, and expert-panel opinions confirming reasonable certainty of safety.
How does REJIMUS assist with dietary ingredient filings?
REJIMUS assists with dietary ingredient filings by evaluating FDA requirements, reviewing scientific literature and historical use, preparing electronic New Dietary Ingredient Notifications, and supporting safety assessments and submission processes.
Why choose professional services for FDA notification support?
The benefits of professional FDA notification support include expert regulatory guidance, accurate documentation, thorough safety evaluations, and efficient submissions, helping companies meet FDA requirements, reduce delays, and confidently navigate NDI or GRAS notifications.
What is the timeline for completing a notification?
The timeline for completing a notification varies by product complexity, available safety data, and review requirements. REJIMUS typically completes preparation within several weeks to a few months, followed by FDA review timelines where applicable.
